FARMACON
ActiveSummary
FARMACON has been active since 1989 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €229,617 and a net result of €16,845. Equity is growing by about 10% per year across the filed financial years. Its solvency ranks better than 36% of 12,678 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Articles of association
- Board ruleHow the board is made up, meets and takes decisions.
- “Één of meerdere bestuurders” (deed in Dutch)
Read from the deeds: 1 provision, deed of 26-03-2024